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Background: Previous publications suggest that nutritional supplements have anti-trypanosome activity in vitro,
although apparent efficacy was not noted in vivo. This study was conducted by experimentally infecting mice with
Trypanosoma brucei brucei to assess the anti-trypanosome activity of various nutritional supplements with the hope
of finding possible application in the treatment of African trypanosomiasis.
Methods: Activities of nutritional supplements were screened in vitro against bloodstream forms of T. b. brucei.
To evaluate selectivity, we used two mammalian cells, Jurkat cells and Vero cells. The IC50 values and selectivity
index values were calculated, and supplements with promising efficacy in vitro were selected for further testing
in vivo. Mice were infected intraperitoneally with 1 × 103 T. b. brucei. We observed parameters for disease progression
such as parasitemia, red blood cell count, white blood cell count, survivability, and splenomegaly. Morphological
profiles after the treatment were analyzed by scanning electron microscopy.
Results: Vitamin D3 showed anti-trypanosome efficacies both in vitro and in vivo. It seemed to have suppressive
effects on parasitemia, and spleen weight was also significantly lower in vitamin D3-treated mice when compared
to non-treated control mice. There was, however, no significant prolonged survivability of infected mice treated
with vitamin D3. Among green tea extracts, polyphenon-60 and epigallocatechin gallate had suppressive effects
against T. b. brucei in vitro, but in vivo efficacies were marginal.
Conclusions: Treatment with nutritional supplements, vitamin D3, and polyphenon-60 seemed to have
anti-trypanosome activity in vitro and protective activity to some extent in vivo, respectively, although those supplements
themselves did not have curable effects. The exact mechanisms of action are not clear, but the significant efficacy in vitro
suggested direct effects of supplements against African trypanosome parasites.
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African trypanosomiasis consisting of human African
trypanosomiasis (HAT) and animal African trypano-
somiasis (AAT/Nagana) are listed as neglected tropical
diseases endemic in sub-Saharan Africa [1, 2]. It is
caused by parasitic protist of the order Kinetoplastida
and genus Trypanosoma. HAT is primarily caused by* Correspondence: matata.vip@tmd.ac.jp
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siense. In Western and Central African subregions, T. b.
gambiense is the major causative parasite of the disease,
while in Eastern Africa, T. b. rhodesiense predominates.
A third closely related subspecies, Trypanosoma brucei
brucei, cannot survive in the human host due to the hu-
man serum lytic factor but is responsible for many
cases of nagana in cattle in East Africa [3, 4].
Trypanosomes are transmitted by insect vector, tsetse
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after a few weeks, they are able to cross the blood-brain
barrier and enter the central nervous system. Once this
occurs, patients show a variety of neurological symp-
toms becoming fatal without proper treatment resulting
in coma and ultimately death [5–7]. Therefore, effective
treatment at the early stage is crucial. The current
drugs available for treatment of trypanosomiasis are
less effective with severe side effects. Furthermore, the
route of administration of these drugs and their optimal
doses should be re-considered to achieve better treat-
ment efficacy [6].
The host immune response system is known to play
an important role in the disease progression and is con-
sidered to be highly essential for the control of the early
phase of parasite replication which may be associated
with host resistance to the parasite proliferation [8]. The
use of nutritional supplements to aid in host response
against protozoan parasites has been studied, some of
which revealed anti-trypanosome effects. Ascorbic acid
(vitamin C) has been shown to aid in combating the oxi-
dative stress injuries in vital organs of mice infected with
Trypanosoma cruzi [9]. Epigallocatechin gallate (an ana-
log of green tea extract) administration to mice showed
significant levels of decreased parasitism and increased
survival rates suggesting that epigallocatechin gallate
may be potentially useful for the protection against T.
cruzi [10]. Zinc supplementation has also shown benefi-
cial activity in the reduction of parasitemia in T. b. bru-
cei-infected mice [11]. Considering the situation that no
safe and effective drugs are available, treatment regimens
using drugs and supplements might be a challenge for
the trypanosomiasis control strategy.
In view of these, we postulated that nutritional sup-
plements may have some inhibitory/protective activity
against T. b. brucei. Thus, we screened various nutri-
tional supplements from different functional groups for
their inhibitory effects in vitro and compounds that
showed promising results were further assessed in vivo
for their protective abilities.
Methods
Parasite strains
T. b. brucei bloodstream forms of strain GUTat 3.1 and
TC221 maintained at Tokyo Medical and Dental Univer-
sity were used for all in vitro and in vivo experimental
procedures. Parasites were cultured in Iscove’s modified
Dulbecco’s medium (IMDM) (Sigma-Aldrich, St. Louis,
MO, USA) supplemented with two mixtures; mixture 1
consisted of 0.1 M HCl, 100 μM hypoxanthine (Sigma-
Aldrich), 30 μM thymidine (Sigma-Aldrich), and 40 μM
adenosine (WAKO, Osaka, Japan) and mixture 2 con-
sisted of a mixture of 1 mM sodium pyruvate (WAKO),
200 μM L-alanine (WAKO), 100 μM glycine (WAKO),20 μM L-ornithine monohydrochloride (Tokyo Kasei,
Tokyo, Japan), 10 μM L-citrullin (Sigma-Aldrich) and
100 μM 2-mercaptoethanol (WAKO), and 200 ml of
distilled water. The adjusted IMDM had a further 10 %
fetal bovine serum (FBS), 2 mM L-glutamine (WAKO),
and 100 U/ml penicillin-100 μg/ml streptomycin added
to it. Parasites were cultured at 37 °C and 5 % CO2
humid atmosphere as described previously [12].
Supplements tested in this study
All supplements used in the experimental protocol are
listed in Table 1. Vitamin D3 (Cayman Chemical, Ann
Arbor, MI, USA), Vitamin C (WAKO), catechin hydrate
(Sigma-Aldrich), polyphenon-60 (Sigma-Aldrich), Vitamin
E (WAKO), epigallocatechin gallate (Sigma-Aldrich), co-
enzyme Q10 (WAKO), and 5-aminolevulinic acid (WAKO)
were tested for their activities against T. b. brucei. Vitamin
D3 was dissolved in 100 % ethanol; the other supplements
were dissolved in 100 % dimethyl sulfoxide (DMSO) be-
fore use. Suramin (WAKO) and curcumin (WAKO) were
used as positive controls.
Efficacy of supplements against T. b. brucei in vitro
Effects of the nine supplements against the bloodstream
form of T. b. brucei GUTat 3.1 were determined using the
alamarBlue method (Sigma-Aldrich) as was shown else-
where [13]. Each well contained 1 × 105 cells in 100 μl
medium with supplement concentrations in 1:2 serial dilu-
tions (100~1.5 μM) except for vitamin D3. Vitamin D3
had a starting concentration of 13 μM and also dissolved
in a 1:2 serial dilution. To check the viability of trypano-
somes at 24 and 48 h, 10 μl of alamarBlue solution was
added to each well at 23 and 47 h of incubation, respect-
ively, followed by further 1 h incubation. Fluorescence was
read in FLUOstar OPTIMA (BMG Labtech, Aylesbury,
UK; λexcitation = 540 nm; λemission = 590 nm) and absorb-
ance measured by TriStar LB941 (Belthold, Oak Ridge,
TN, USA). We determined selectivity index of tested sup-
plements against trypanosome cells by comparing the effi-
cacies against two mammalian cells, Jurkat cells and Vero
cells. Cells were cultured in conditioned medium of
Roswell Park Memorial Institute medium-1640 (RPMI-
1640) with 10 % FBS or Dulbecco’s modified Eagle’s
medium (D-MEM) (WAKO) for 24 h and were exposed
to various concentrations of supplements for 48 h. Sensi-
tivity of the mammalian cells was measured using alamar-
Blue assay, as described previously [13].
Testing in experimental murine infection model
Female BALB/c mice aged 6 weeks were purchased from
CLEA (Tokyo, Japan). Mice were randomly assigned into
five mice/group and treated with three test supplements,
vitamin D3, polyphenon-60, catechin hydrate, positive
control (suramin), and a healthy control (infection-free).
Table 1 Supplements and chemicals selected for in vitro screening of T. b. brucei
Chemical name Structural formula Molecular weight (g/mol) Function
Polyphenon-60 290.3 Mainly anti-oxidative effects and also anti-cancer,
anti-inflammatory [31]
Catechin hydrate 290.3 Able to impart thermal stability to collagen [32]
Epigallocatechin gallate 458.4 Modulates cognitive function and brain activity [33]
5-Aminolevrinic acid 167.6 Helps in heme synthesis, heme protein design [34]
Coenzyme Q10 863.34 Act as an anti-oxidant, needed for basic cellular
function [35]
Vitamin C 198.11 An anti-oxidant, required for collagen synthesis
and biosynthesis of certain hormones [36]
Vitamin D3 384.64 An immunomodulator, supports the brain and
nervous system [37]
Vitamin E 430.71 Essential for neurological function [38]
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Table 2 Screening IC50 values of nutritional supplements against




Jurkat cells SI Vero cells SI
5-Aminolevrinic acid 51.3 μM >100 μM >1.95 >100 μM >1.95
Catechin hydrate 53.6 >100 >1.86 >100 >1.86
Coenzyme Q10 >100 >100 ND >100 ND
Epigallocatechin gallate 8.40 35.7 4.25 39.8 4.74
Polyphenon-60 16.9 26.4 1.56 41.2 2.44
Vitamin C 58.6 >100 >1.70 >100 >1.70
Vitamin D3 4.58 >100 >21.8 >100 >21.8
Vitamin E 28.6 >100 >3.49 >100 >3.49
Curcumin 6.05 34.3 5.66 90.4 >1.70
Suramin 1.18 >100 >84.8 >100 >84.8
ND not determined, SI selectivity index
aT. b. brucei GUTat 3.1 strain was used
Table 1 Supplements and chemicals selected for in vitro screening of T. b. brucei (Continued)
Curcumin 368.38 Exhibits anti-cancer, chemo- preventive, chemo-
and radio-sensitization properties [39]
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ous report [14]. Catechin hydrate and polyphenon-60
dissolved in DMSO were administered at a dose of
50 mg/kg via intraperitoneal route every 2 days in ex-
perimental period. Vitamin D3 was dissolved in ethanol
and administered at a dose of 250 ng/kg by subcutane-
ous injection. After that, mice were infected with 1 × 103
T. b. brucei TC221 via the peritoneum. Suramin was
used at a dose of 30 mg/kg, while phosphate-buffered sa-
line (PBS) (pH 7.4) was used as a positive control. The
parameters used to assess the disease progression were
body weight, level of parasitemia, total red blood cell count
(RBC count), total white blood cell count (WBC count),
survivability, and splenomegaly. All parameters were mea-
sured independently by two researchers to reduce bias and
for comparison. In cases of discordant results, the pa-
rameters were measured again for confirmation and
consistency. Animal study was done in strict accord-
ance with the guidelines approved by the Committee of
Animal Ethics of Tokyo Medical and Dental University
(0160295A, 2015, and 0170274A, 2016).
Scanning electron microscopy
T. b. brucei GUTat 3.1 treated with supplements in vitro
were fixed in 3.5 % glutaraldehyde placed in a fridge at
4 °C for overnight fixation. The next day, it was washed
with PBS. Small droplets containing parasites were put
on poly-lysine coated slides. Samples on slide glass were
then stained in 1 % osmium tetraoxide (OsO4) and dehy-
drated in a series of graded ethanol concentrations for
10 min each. They were dried in a critical point dryer
(Hitachi, Tokyo, Japan) using liquid carbon dioxide. The
samples were then sputter coated with platinum in an ion
sputter coater (Hitachi). Digital images were collected
using a scanning electron microscope (S-4500, Hitachi)
operating at 10 kV at 500 to 40,000 times magnification.
Data analysis
Data were presented as mean values with standard devi-
ation. The data were subjected to analysis of variance
using ANOVA. Means were considered significant at
95 % confidence interval with a p value <0.05.
Results
In vitro effects of the supplements against T. b. brucei
Nutritional supplements with possible anti-trypanosome
efficacy were assayed for inhibitory activity against T. b.brucei. In the in vitro assay, polyphenon-60, vitamin D3,
and epigallocatechin gallate showed relatively low IC50
values of 16.9, 4.58, and 8.40 μM, respectively, which were,
however, less effective than that of suramin (1.18 μM)
(Table 2). From the results obtained by testing those sup-
plements against mammalian cells, the selectivity index of
vitamin D3 was good enough, but other supplements had
medium or low selectivity index values (Table 2). Based
on these in vitro results, we selected vitamin D3 and
polyphenon-60 to observe the effects in vivo.
In vivo observation of anti-trypanosome activity of
supplements
Selected nutritional supplements were assessed for five pa-
rameters in vivo. During the 10 days before trypanosome
infection, treatments with polyphenon-60 made no signifi-
cant changes in body weight and RBC and WBC count,
suggesting no apparent negative effects for mice. After
trypanosome infection, efficacies of supplement treatment
on three parameters assessed are summarized in Table 3.
In brief, there was no detectable difference in body weight
but continuous administration of vitamin D3 may cause
statistically significant differences in body weight. When
we compared results of parameters of RBC count and
WBC count with infection-free control mice, RBC count
recovered by vitamin D3 treatment, polyphenon-60, and
suramin, indicated that treated mice recovered from
anemic conditions induced by infection with T. b. brucei.
Fig. 1 Reductions of parasitemia level of supplement-treated mice.
a Parasitemia levels in mice infected with T. b. brucei GUTat 3.1 and
treated with 500 ng/kg vitamin D3 and 250 ng/kg vitaminD3. Solid
triangles (▲) with a dotted line show parasitemia of 500 ng/kg vitamin
D3-treated group. Solid circles (●) with a solid line, closed squares (■) with
broken line, and solid diamonds (◆) with a solid line show 250 ng/kg
vitamin D3-treated group, non-treated control group, and suramin-
treated group, respectively. b Parasitemia levels in mice infected with T.
b. brucei and treated with 50 mg/kg polyphenon-60. Solid circles (●)
with solid line show survival rates of polyphenon-60-treated group, and
solid squares (■) with a broken line show those of non-treated control
group. Vitamin D3-inhibited level of parasitemia was significantly lower
than that of control-infected mice (P < 0.05). Polyphenon-60-treated
group also showed inhibition, but it was not statistically significant
(P = 0.056)
Fig. 2 Survivability of trypanosome-infected mice treated with
supplements. a Survival rates of vitamin D3-treated mice infected
with T. b. brucei GUTat3.1. Solid triangles (▲) with a dotted line show
survival rate of 500 ng/kg vitamin D3-treated group. Solid circles (●) with
a solid line, closed squares (■) with a broken line, and solid diamonds (◆)
with dotted line show 250 ng/kg vitamin D3-treated group, non-treated
control group, and suramin-treated group, respectively. b Survival rates
of polyphenon-60-treated mice infected with T. b. brucei GUTat 3.1.
Solid circles (●) with solid line show survival rates of polyphenon-60-
treated group and solid squares (■) with a broken line show those of
non-treated control group. Polyphenon-60-treated mice showed slight
prolongation of survivability, but those were not statistically significant
difference in comparison with that of non-treated control
Table 3 Body weight, RBC, and WBC levels in mice after pre- and post-infection stratified according to supplement administration
Parameters T. b. brucei infection (+) and treatment with
Infection-free No treatment Vitamin D3 Polyphenon-60 Suramin
Body weight (g) Pre-infectionb 20.0 ± 1.05 22.4 ± 1.32 22.2 ± 0.89
Post-infectionc 21.6 ± 0.94 20.4 ± 1.46 18.6 ± 0.96 20.3 ± 0.56
RBC (×106/ml) Pre-infectionb 8.30 ± 0.62 8.45 ± 0.37 11.2 ± 0.22
Post-infectionc 6.42 ± 0.94a 10.9 ± 0.11 8.10 ± 0.23 9.90 ± 0.97
WBC (×103/ml) Pre-infectionb 5.90 ± 0.11 4.40 ± 0.14 4.17 ± 0.56
Post-infectionc 4.60 ± 0.15a 2.20 ± 0.44a 3.50 ± 0.16a 3.70 ± 0.56a
aStatistically significant differences between the four groups and infection-free group are shown after analysis of variance (ANOVA). p value is less than 0.05 to the
chosen significance level
bPre-infection: on day 4 of polyphenon-60 treatment but not yet infected with T. b brucei GUTat 3.1 strain
cPost-infection: 7 days after infection
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Fig. 3 Comparing spleen weight treated or non-treated with vitamin D3. Spleen weight was compared among four groups of mice: a infection-free,
b 250 ng/kg vitamin D3-treated, c 500 ng/kg vitamin D3-treated, and d non-treated control, while b–d were infected. There was a significant reduction
in spleen weight in vitamin-D3-treated groups compared with treatment-free control mice
Jamal et al. Tropical Medicine and Health  (2016) 44:26 Page 6 of 9On the other hand, WBC count significantly reduced in
infected groups (p < 0.05), and treatment with supple-
ments (vitamin D3 and polyphenon-60) and suramin
resulted in more profound leukopenic conditions. Vita-
min D3 provided significant decrease in parasitemiaFig. 4 SEM morphology assessment of T. b. brucei GUTat 3.1 strains culture
b suramin-treated, c vitamin D3, and d epigallocatechin gallate (an analog of
of the flagella from the body and surface damage. In cases of vitamin D
showing irregular knot-formation, there was apparent damage in the fla
showed damaged cell membranecompared with that of non-treated control mice (Fig. 1)
and seemed to be dose-dependent (Fig. 1). Polyphenon-
60 showed suppression of parasites, but it showed
marginal statistical difference (p = 0.056). Although
survivability of mice treated with polyphenon-60 wasd in vitro with various treatment protocols. a Non-treated control,
green tea extract)-treated. Suramin-treated parasites showed detachment
3 or polyphenon-60 treatment, slight changes of the cell surface
gella structure. Arrow head showed flagella damage, and Arrow
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when compared with that of non-treated control (Fig. 2).
Suramin-treated group showed 100 % survivability during
the period of our observation. Splenomegaly in vitamin
D3-treated mice was significantly suppressed in compari-
son with non-treated mice in a dose-dependent manner
(p < 0.05) (Fig. 3). Considering that splenomegaly is one of
the signs of disease progression of African trypanosomia-
sis, treatment of vitamin D3 might have had some protect-
ive effect.Scanning electron microscopy assessment of treated
trypanosomes
Morphological profiles of T. b. brucei treated with vita-
min D3, were assessed by SEM (Fig. 4). Suramin-treated
parasites showed apparent changes such as displacement
of flagellum from the body surface, pouching, and other
related damage to the cell surface. In comparison with
non-treated trypanosomes, we observed slightly jagged
surface of vitamin D3-treated parasites, damaged flagel-
lum was observed in the suramin treatment group.Discussion
Human African trypanosomiasis is still a disease of tre-
mendous public health and economic importance, but
the major challenge in the control is the development of
safe and effective drugs available for treatment [15]. In
parallel with therapeutic drugs, various nutritional sup-
plements have been tested for inhibitory effects, if not
therapeutic, against African trypanosomiasis [10, 11, 16].
In our study, we examined the possible efficacy of
available nutritional supplements in enhancing host
defense response to suppress parasite growth and dis-
ease progression.
Results obtained here suggested that vitamin D3 and
polyphenon-60 showed anti-trypanosome activity both
in vitro and in vivo, while catechin hydrate showed only
a faint effect in vivo (data not shown). Vitamin D3
showed a parasite growth inhibition in vitro with a good
selectivity index. Although vitamin D3 failed to show
curable effects in vivo, significant parasite growth inhib-
ition was observed in vivo, and also splenomegaly during
the disease course was suppressed. In this sense, vitamin
D3 cannot be a therapeutic drug for African trypano-
somiasis in the protocol tested here which is severely
dose dependent, but it might be expected to enhance ef-
ficacy of therapeutic drugs. Previous researchers have
postulated that vitamin D reduced the risk of certain in-
fections through multiple mechanisms [17, 18]. It has
been shown that vitamin D boosts innate immunity by
modulating production of anti-microbial peptides (AMPs)
and cytokine response [19, 20]. For an experimental T.
cruzi infection, vitamin D treatment favored the hosts beable to overcome acute phase of the disease and to pro-
long survivability in the chronic phase [18].
When efficacy of vitamin D was discussed, vitamin D
was likely to have an effect indirectly to the pathogen.
For instance, vitamin D exerts an immunomodulatory
effect through complex interactions with vitamin D re-
ceptors (VDR) [21]. VDR is a member of the superfam-
ily of nuclear hormone receptors expressed on immune
cells in humans [22, 23]. Circulating vitamin D levels
has a direct influence on macrophages, increasing their
oxidative potential [24]. There was a report showing that
vitamin D3 facilitates neutrophil motility and phagocytic
function [25]. All those seem to show that the efficacy of
vitamin D was indirect to the pathogen, but rather im-
mune cells were activated and subsequently suppressed
parasite growth in vivo. In this sense, our observation
suggests that vitamin D3 could have direct effect(s) against
T. b. brucei, since treatment of vitamin D3 in vitro in the
absence of host immune cells also has detectable inhibi-
tory effects.
Polyphenon-60 is a derivative of green tea extracts. It
has been suggested that green tea extracts including cat-
echin seem to have inhibitory effects against T. b brucei
in vitro. Polyphenon-60 also showed significant inhibitory
effect against parasite proliferation in vitro. Furthermore,
slight prolongation of survivability was observed in in-
fected mice treated with polyphenon-60, although it was
not statistically significant. Administration of tea extracts
has also been previously shown to prevent reduction in al-
bumin concentration during T. b. brucei infection in mice,
thereby suggesting decreased inflammation due to the
trypanosome parasite [26]. Polyphenon-60 has extensive
protein-denaturing characteristics as shown against influ-
enza virus. Alternatively, polyphenon-60 is a supplement
with anti-oxidative effects and immune-enhancing effects
as has been already reported [27]. It is possible to specu-
late that those functions contributed to anti-trypanosome
activities of polyphenon-60 in our study. It is again likely
that polyphenon-60 could support and/or enhance the ef-
ficacy of anti-trypanosome drugs.
Nutritional supplements are not necessarily safe in daily
use. Previous research had shown that vitamin D3 treat-
ment produced calcinosis lesions in the myocardium,
coronary and kidney arteries, and may have induced mice
death [28]. In our study, several mice died during the treat-
ment of vitamin D3 even in the situation of relatively low
parasitemia level (Fig. 1) while using high dose of vitamin
D3 (500 ng/kg). Although we did not study the possible
histopathological changes due to vitamin D3 treatment,
similar phenomena were observed by one of the authors in
the murine experimental malaria (KY, manuscript in prep-
aration). Probably, T. b. brucei infection could produce
acute and chronic fatal conditions just like splenomegaly
to the host [29]. On the other hand, polyphenon-60 has
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high doses to mice, where they induce reactive oxygen
species formation, and affect mitochondrial membrane
potential thereby causing death [30]. In the murine ex-
perimental malaria, high doses of polyphenon-60 ad-
ministration caused significant toxicity and mortality in
the infected mice (KY, unpublished data). Such infor-
mation strongly suggests that supplement treatment
should be under strict control to avoid negative effects.
More detailed studies are needed to establish the opti-
mal protocol for safe and effective treatment of supple-
ments with anti-trypanosome activities.
Conclusions
We observed inhibitory effects of vitamin D3 against T. b.
brucei in vitro and possibly in vivo. We were not able to
observe curable effects for this supplement in vivo; several
parameters of disease progression were improved by the
treatment with this supplement. The results obtained sug-
gest that treatment with nutritional supplements may pos-
sibly have protective/prophylactic roles; we therefore
recommend that vitamin D3 and green tea extracts could
be included in the treatment protocols. In addition, fur-
ther test should be conducted to confirm the efficacy of
dietary supplements as treatment regimens in trypano-
some infections.
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